Chiral Quest was founded in 2000, we provide chemical development and contract manufacturing services to meet demand at all stages of chemical development(kilo-lab, pilot-plant and commercial scale manufacture). Chiral Quest has a manufacturing site in Jiangxi province (www.cqlonglife.cn), headquarters and R&D centre located in Suzhou Industrial Park; and three overseas offices located in USA, Europe and India. We have expertise in asymmetric hydrogenation, multi-step synthesis and cryogenic reactions. With 5 granted U.S. patents for asymmetric hydrogenation catalysts and 6 process patents for innovative routes to generic API intermediates.
Year Established: 2000
Total Assets(USD): 500,000 to 99,999,999
Total Number of Staff: 10-50
Main Competitive Advantages: International Approvals/Standards,Experienced R&D Staff,Contract Manufacturing (CRO,CMO),Small Orders Accepted,Quality Service
Business Type: Manufacturer
R&D Capacity: Own Brand
Annual Turnover(USD) : 500,000 to 99,999,999
Main Sales Markets : North America,Central/South America,Western Europe,Eastern Europe,Australasia,Asia,Middle East,Africa
Subscribe to the latest newsletter of Virtual Expo Connect
Relugolix Intermediate (308831-93-8)
Valbenzanine Intermediate (CAS 20232-39-7)
Valbenzanine Intermediate (91342-74-4)
Brivaracetam Intermediate (CAS 63095-51-2)